Press Releases ANGLE plc

Equities

AGL

GB0034330679

Delayed London S.E. Other stock markets 10:18:14 2024-05-13 EDT			5-day change	1st Jan Change
20.32 ^GBX	-3.23%		-4.37%	+72.95%

05-03	Angle shares up on assay development deal with AstraZeneca	AN
05-03	Angle shares up on assay development deal with AstraZenaca	AN

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giant	05-08	AQ
ANGLE PLC - NEW COMMERCIAL AGREEMENT WITH LARGE PHARMA	05-06	AQ
ANGLE partners with AstraZeneca in groundbreaking oncology contract	04-24	AQ
ANGLE PLC - US AND EU PATENTS FOR ANGLE'S INNOVATIVE CELLKEEP SLIDE	04-23	AQ
ANGLE achieves breakthrough with EU patent for CellKeep technology, with the US to follow	04-23	AQ
ANGLE PLC - PARSORTIX HER2 ASSAY SHOWCASED AT PRESTIGIOUS INTERNATIONAL CANCER CONFERENCE	04-09	AQ
ANGLE PLC - REVIEW PAPER ON MOLECULAR ANALYSIS OF PARSORTIX CTC HARVEST HIGHLIGHTS POTENTIAL UTILITY IN PRECISION ONCOLOGY	03-25	AQ
ANGLE PLC - PARSORTIX SYSTEM AND ASSAYS BEING SHOWCASED AT A LEADING EUROPEAN BREAST CANCER CONFERENCE	03-25	AQ
ANGLE PLC - REVIEW PAPER ON MOLECULAR ANALYSIS OF PARSORTIX CTC HARVEST HIGHLIGHTS POTENTIAL UTILITY IN PRECISION ONCOLOGY	01-23	AQ
ANGLE PLC - BREAKTHROUGH CLINICAL RESULTS PROVIDE A UNIQUE INSIGHT INTO THE PROGRESSION OF EACH PATIENT'S CANCER	01-05	AQ
ANGLE LAUNCHES PORTRAIT+ CTC KIT AT SAN ANTONIO BREAST CANCER SYMPOSIUM	12-06	AQ
ANGLE LAUNCHES PD-L1 TEST TO SUPPORT CANCER THERAPY STUDIES	11-10	AQ
ANGLE PLC - TRADING AND BUSINESS UPDATE	11-10	AQ
ANGLE PLC - RESEARCH DEMONSTRATES POTENTIAL OF THE PARSORTIX SYSTEM TO SUPPORT POWERFUL CHARACTERISATION OF CTCS IN HEAD AND NECK CANCER	23-10-26	AQ
ANGLE PLC - PARSORTIX SYSTEM OUTPERFORMS CURRENT LABORATORY STANDARD FOR DISSEMINATED TUMOUR CELL HARVEST	23-10-04	AQ
Angle Plc - Launch of Portrait Flex Circulating Tumor Cell Assay	23-09-05	AQ
ANGLE : Annual Report December 2022	23-05-25	PU
ANGLE PLC has opened up "a major market opportunity" with breast cancer partnership	23-04-20	AQ
ANGLE : Interim Report June 2022	22-11-13	PU
Presentation slides 29 September 2022: Interim Results for the Six Months Ended 30 June 2022	22-09-29	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ANGLE plc

Equities

AGL

GB0034330679

Press Releases

Filters